A little more than five months after netting $95.6 million in its first follow-on offering, Bluebird Bio Inc. is leveraging its soaring share value (NASDAQ:BLUE) for a secondary offering, planning to raise $211.4 million through the sale of about 2.7 million shares priced at $85 each.